292665
An examination of barriers to condom use among ghanaians
Methods: Data from 3,517 sexually active individuals from the Condom Barrier Scale (CBS) were analyzed. Exploratory factor analysis (EFA) was employed to identify latent-factors among 29 items. Standardized factor scores were used to create categorical variables based on tertiles for each factor. Binary logistic regression predicted condom use based on latent-factors.
Results: Thirteen items were removed via series of EFAs leaving 16 items and subsequent extraction of three latent factors; partner barrier (PB), effect on sexual experience (ESE) and motivational barriers (MB). Participants in higher tertiles of PB were more likely to report condom use compared to 1st tertile (OR= 1.31, CI 1.05-1.64, for 2nd tertile; and OR= 2.50, CI 1.96-3.13, for 3rd tertile). MB-participants in higher tertiles were more likely to report condom use compared to 1st tertile (OR= 1.51, CI 1.21-1.89, for 2nd tertile; and OR= 4.10, CI 3.24-5.19, for 3rd tertile). For ESE, participants in higher tertiles were less likely to report condom use compared to 1st tertile (OR= .57, CI.46-.70, for 2nd tertile; and OR= .57, CI .46-.71, for 3rd tertile).
Discussion: Partner barriers, effect on sex, and motivational barriers are significant constructs to consider as part of interventions to reduce condom use barriers among Ghanaians.
Social and behavioral sciences
Learning Objectives:
Identify significant constructs representing barriers to Condom use among Ghanaians
Keywords: HIV Interventions, Theory
Qualified on the content I am responsible for because: I am the co-PI of the national level project from which the data for this study came from. In addition, I am the country (Ghana) coordinator for the Ghana Global School-based Student Health Survey; a collaboration between Ghana, the World Health Organization and US Centers for Disease Control and Prevention.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.